Compare Kymera Therapeutics Inc. Common Stock (KYMR) vs Rollins Inc. Common Stock (ROL) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Kymera Therapeutics Inc. Common Stock vs Rollins Inc. Common Stock — how do they compare? Kymera Therapeutics Inc. Common Stock trades at $106.9 (market cap $8.87B), while Rollins Inc. Common Stock trades at $32.61 (market cap $15.47B). The key difference: Rollins Inc. Common Stock is the larger of the two by market cap, and Rollins Inc. Common Stock pays a 2.27% dividend while Kymera Therapeutics Inc. Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold Kymera Therapeutics Inc. Common Stock for 0 Days and Rollins Inc. Common Stock for 0 Days on average.
| KYMR | ROL | |
|---|---|---|
Market Cap | $8.87B | $15.47B |
Volume | 779,107 | 6,712,154 |
Sector | Health | Industrials |
52-Week High | $127.31 | $65.60 |
52-Week Low | $55.80 | $29.69 |
Typical Hold Time | 0 Days | 0 Days |
Enterprise Value | $8.26B | $16.48B |
Dividend Yield | — | 2.27% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
About Kymera Therapeutics Inc. Common Stock
Kymera Therapeutics, Inc. is a biopharmaceutical company developing small-molecule medicines based on targeted protein degradation, using its Pegasus platform to direct the body's natural protein-disposal system against disease-causing proteins.
Read more on KYMR →About Rollins Inc. Common Stock
Rollins Inc. provides pest control services to residential and commercial customers through its family of brands, including Orkin, across dozens of countries.
Read more on ROL →
